Toggle navigation
Home
Search
Services
Blog
Contact
About
Development of a Human Monoclonal Antibody for Inhalational Anthrax
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
The Role of Innate Cells in the Pathogenesis of Leishmania Braziliensis Infection
Development of Innovative and Best Practices in the Implementation of the Retail
MAGL Inhibition in Prevention and Treatment of Alzheimer's Disease
The Political Economy of Tobacco Control in Southeast Asia
Investigation of A Novel Enzyme Catalyzed Rearrangement
Recently added grants:
The Anti-angiogenic VEGF165b and VEGFR1 Signaling in Peripheral Artery Disease
Molecular Control of Cardiomyocyte Mitophagy by the RhoGAP GRAF1
A Precision Medicine Approach to Arrhythmogenic Cardiomyopathy
Predictive and systems modeling of exosome cargo
Novel Assessments of Technical and Non-Technical Cardiac Surgery Quality
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research and Development Contracts (N01)
Project #
272200700033C-2-0-1
Application #
7567309
Study Section
Project Start
2007-09-28
Project End
2011-09-29
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 AI
Development of a Human Monoclonal Antibody for Inhalational Anthrax
/ Pharmathene, Inc.
$1,998,109
NIH 2007
N01 AI
Development of a Human Monoclonal Antibody for Inhalational Anthrax
/
Comments
Be the first to comment on this grant